隔离肢体灌注作为局部晚期肢体软组织肉瘤的保肢策略
本研究回顾1994至2016年5家机构77例患者84次隔离肢体灌注(ILI),采用美法仑和放线菌素D循环30分钟后冲洗。3个月总客观缓解率58%,上肢37%显著低于下肢66%(p=0.03)。中位随访20.6个月,总保肢率77.9%,中位总生存44.3个月,缓解者远处转移无生存更长(p=0.01)。
要点
- ILI可使半数面临截肢的肢体软组织肉瘤患者获得客观缓解。
- 下肢ILI的3个月客观缓解率显著高于上肢(66% vs 37%,p=0.03)。
- 总保肢率达77.9%,中位总生存44.3个月。
核心结论
- 隔离肢体灌注对面临截肢的肢体软组织肉瘤患者可使半数获得客观缓解,并为绝大多数患者提供持久保肢。
- 该操作耐受良好,无严重并发症。
研究设计与样本
- 回顾性多中心研究,1994至2016年5家机构共77例患者接受84次隔离肢体灌注。
- 采用美法仑和放线菌素D在肢体完全止血带阻断后循环30分钟,随后主动冲洗以防止全身暴露。
主要发现
- 上肢19例(21次灌注),下肢58例(63次灌注)。
- 整个队列3个月总客观缓解率为58%,上肢37%与下肢66%之间差异有统计学意义(p=0.03)。
- 中位随访20.6个月(范围0.6至146.1个月),总保肢率为77.9%。
- 因疾病进展而截肢者,中位至截肢时间为4.5个月。
- 中位随访20.6个月,整个队列中位总生存为44.3个月。
临床怎么用
- 对于局部晚期、治疗抵抗的肢体软组织肉瘤,ILI可作为保肢策略考虑。
- 下肢肉瘤的ILI缓解率可能高于上肢,选择病例时需考虑部位差异。
局限性
- 回顾性研究,样本量有限(77例患者,84次灌注)。
- 随访时间较短(中位20.6个月),长期结局需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Treatment-resistant, locally advanced soft tissue sarcomas often require amputation for complete tumor extirpation. Isolated limb infusion (ILI) selectively delivers high-dose chemotherapy to the extremity in an attempt to achieve limb salvage. The aim of this study was to report perioperative and oncologic outcomes after ILI in patients with extremity soft tissue sarcomas. STUDY DESIGN: From 1994 to 2016, 77 patients underwent 84 ILIs at a total of 5 institutions. Melphalan and actinomycin D were circulated for 30 minutes after complete tourniquet occlusion of the limb, then actively washed out to prevent systemic exposure. RESULTS: The procedure was performed in an upper extremity on 19 patients (21 infusions) and in a lower extremity on 58 patients (63 infusions). The 3-month overall response rate (ORR) for the entire cohort was 58%, and there was a statistically significant difference (p = 0.03) between upper (37%) and lower extremity (66%) ORR. With median follow-up of 20.6 months (range 0.6 to 146.1 months), the overall limb salvage rate was 77.9%. For those who underwent amputation due to progression of disease, the median time to amputation was 4.5 months. With a median follow-up of 20.6 months, the median overall survival for the entire cohort was 44.3 months. The distant metastatic-free survival was longer for responders than nonresponders (p = 0.01), though the disease-specific survival was not different for the same groups (p = 0.2). CONCLUSIONS: Isolated limb infusion for extremity soft tissue sarcoma results in an objective response for half of the patients who are otherwise facing amputation, and offers prolonged limb salvage for the vast majority of patients. The procedure is well tolerated without serious complications.
引用
- Mullinax JE, Kroon HM, Thompson JF, et al. Isolated Limb Infusion as a Limb Salvage Strategy for Locally Advanced Extremity Sarcoma. J Am Coll Surg. 2017. PMID: 28214556. doi:10.1016/j.jamcollsurg.2016.12.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。